Table 2.
Diseases | Sample matrix | Analyte | Detection limit | Electrodes used | References |
---|---|---|---|---|---|
Cancer, lung infections, kidney disorder | Blood | Lead | 0.001 µM | Hg | [68] |
1.2 µg dL−1* | Hg/screen-printed | [69] | |||
0.46 ppb | Hg microelectrode | [76] | |||
0.03 μg mL−1 | Mercury film/carbon | [67] | |||
– | Bismuth | [77] | |||
0.23 ppb | Hg-plated pre-anodized screen-printed carbon | [78] | |||
Cadmium | 0.002 µM | Mercury | [68] | ||
– | Bismuth | [78] | |||
0.06 μg mL−1 | Mercury film/carbon | [67] | |||
0.1 nM | Nafion-coated mercury-plated glassy carbon | [79] | |||
Zinc | 0.01 µM | Mercury | [69] | ||
0.6 μg mL−1 | Mercury film/carbon | [68] | |||
Cooper | 0.01 µM | Mercury | [69] | ||
0.02 μg mL−1 | Mercury film/carbon | [68] | |||
Urine | Lead | 0.5 ppb | GCE/ferromagnetic rod | [65] | |
0.44 ppb | Hg microelectrode | [80] | |||
Hyponatremia | Urine | Sodium | – | Ion-selective (ISE-27504-30; Cole-palmer) | [65] |
* Lower limit of linear range in calibration